CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Airvo 2; High-Flow nasal cannula systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03590457
NCT03590457N/ACompleted

The Impact of High-Flow Nasal Cannula on Swallow Function

Rush University Medical Center·interventional·Posted Jul 18, 2018·Updated Sep 27, 2022

In Brief

A clinical study evaluating Airvo 2; High-Flow nasal cannula system for Swallowing Disorder and Respiratory Insufficiency. Completed, enrolled 18 participants across 1 site.

Detailed Summary

Background: High-flow nasal cannula (HFNC) is a non-invasive heated and humidified oxygen delivery device that is capable of delivering high-flow rates. It is a relatively new modality that has been introduced as an alternative to conventional oxygen therapy. The clinical value of the use of HFNC is not limited to its ventilation and oxygenation effects, it enables the patient to talk and is purported to permit oral feeding during oxygen therapy despite the limited evidence regarding its impact on swallow function. This study will determine the impact of different flow rates of a high-flow nasal cannula on spontaneous swallowing frequency at rest and swallowing effort and timing while swallowing. Methods: This is a prospective study designed to measure swallowing frequency and swallowing effort in fifty healthy adult volunteers. Participants will receive three levels of HFNC flow rates (30, 45, and 60 L/min) through nasal prongs. The study participants will be asked to swallow measured amounts of water and applesauce and subjected to each flow rate for 15 minutes. Swallowing effort measurement through surface electromyography (sEMG) will be recorded at baseline and the three levels of HFNC flow rates interventions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 18, 2018
Enrollment StartJun 22, 2018
Primary CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.0 years ago

Interventions

Airvo 2; High-Flow nasal cannula systemdevice

Noninvasive device used to deliver humidified oxygen at high flow rates up to 60 liters per minute